Table 4:
Multivariate logistic analysis. Association of sociodemographic factors with vascular risk factor at goal and use of stroke preventive drugs agents among stroke/TIA participants.
| HTN at Goal OR (95% CI) (n=387) |
Diabetes at Goal OR (95% CI) (n=380) |
Dyslipidemia at Goal OR (95% CI) (n=378) |
Atrial Fibrillation on anticoagulation OR (95% CI) (n=380) |
On Treatment with Antithrombotics OR (95% CI) (n=388) |
On Treatment with Statins OR (95% CI) (n=380) |
On Treatment with Antithrombotics and statins OR (95% CI) (n=388) |
|
|---|---|---|---|---|---|---|---|
| Age* | 0.95(0.92–0.97) | 0.96(0.93–0.99) | 0.98(0.95–1.01) | 0.99(0.93–1.05) | 1.06(1.03–1.08) | 1.08(1.05–1.11) | 1.06(1.03–1.10) |
| Female | 0.79(0.42–1.48) | 1.19(0.58–2.46) | 0.49(0.28–0.86) | 0.56(0.16–1.95) | 1.16(0.65–2.07) | 1.06(0.57–1.98) | 0.88(0.46–1.71) |
| >High School | 0.55(0.29–1.03) | 1.83(0.87–3.88) | 0.67(0.39–1.17) | 0.65(0.16–2.63) | 1.03(0.55–1.94) | 0.99(0.50–1.93) | 1.12(0.54–2.32) |
| Income >20,000 | 1.15(0.58–2.30) | 1.32(0.64–2.73) | 0.88(0.45–1.75) | 1.61(0.54–4.81) | 0.68(0.37–1.23) | 1.40(0.77–2.56) | 1.08(0.55–2.15) |
| English as preferred language | 1.28(0.57–2.90) | 0.25(0.12–0.55) | 0.91(0.43–1.96) | 2.63(0.58–11.95) | 1.28(0.64–2.53) | 1.26(0.60–2.66) | 1.05(0.49–2.21) |
| Immigrant ≥10 years in the US** | 1.21(0.45–3.22) | 0.06(0.01–0.32) | 0.66(0.27–1.60) | 0.18(0.04–0.70) | 1.66(0.63–4.37) | 1.44(0.52–3.94) | 1.53(0.50–4.67) |
| US born** | 2.27(0.52–9.85) | 0.03(0.00–0.24) | 0.91(0.30–2.76) | 3.58(0.40–32.09) | 3.21(0.93–11.13) | 2.01(0.54–7.53) | 3.26(0.78–13.64) |
| No Health Insurance | 1.43(0.69–2.99) | 1.39(0.55–3.49) | 0.42(0.18–0.95) | 0.47(0.05–4.42) | 0.91(0.47–1.77) | 0.47(0.23–0.97) | 0.66(0.30–1.44) |
Each variable was adjusted by the rest of the variables included in the table.
Per year
Immigrant <10 years in the US as reference